홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium hydride → ethyl (2S)-2-(tert-butoxy)-2-[(20S,22Z)-15,16-difluoro-4,20,26-trimethyl-11,19,25-trioxa-1,5,7,8-tetraazapentacyclo[24.2.2.16,9.02,7.013,18]hentriaconta-2,4,6(31),8,13(18),14,16,22-octaen-3-yl]acetate

HRID 921131
인쇄

반응식

HRID 921131 반응식
[CH2:1]([O:4][C:5]1([CH3:34])[CH2:10][CH2:9][N:8]([C:11]2[N:16]3[N:17]=[C:18]([CH2:20]I)[CH:19]=[C:15]3[N:14]=[C:13]([CH3:22])[C:12]=2[C@H:23]([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])[C:24]([O:26][CH2:27][CH3:28])=[O:25])[CH2:7][CH2:6]1)[CH:2]=[CH2:3].[F:35][C:36]1[C:41]([F:42])=[CH:40][C:39]([CH2:43][OH:44])=[C:38]([O:45][C@H:46]([CH2:48]C=C)[CH3:47])[CH:37]=1.[H-].[Na+]>CN(C=O)C.CCOC(C)=O.ClCCCl.CC1C=C(C)C(N2C(=[Ru](Cl)(Cl)=CC3C=CC=CC=3OC(C)C)N(C3C(C)=CC(C)=CC=3C)CC2)=C(C)C=1.[Cu]I>[C:30]([O:29][C@@H:23]([C:12]1[C:13]([CH3:22])=[N:14][C:15]2=[CH:19][C:18]3=[N:17][N:16]2[C:11]=1[N:8]1[CH2:9][CH2:10][C:5]([CH3:34])([O:4][CH2:1][CH:2]=[CH:3][CH2:47][C@H:46]([CH3:48])[O:45][C:38]2[CH:37]=[C:36]([F:35])[C:41]([F:42])=[CH:40][C:39]=2[CH2:43][O:44][CH2:20]3)[CH2:6][CH2:7]1)[C:24]([O:26][CH2:27][CH3:28])=[O:25])([CH3:33])([CH3:32])[CH3:31]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 3

HCID 24758Sodium hydrideHCID 118307066(S)-(4,5-difluoro-2-(pent-4-en-2-yloxy)phenyl)methanolHCID 118318796(S)-ethyl 2-(7-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(iodomethyl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-(tert-butoxy)acetate

생성물 1

HCID 118318807ethyl (2S)-2-(tert-butoxy)-2-[(20S,22Z)-15,16-difluoro-4,20,26-trimethyl-11,19,25-trioxa-1,5,7,8-tetraazapentacyclo[24.2.2.16,9.02,7.013,18]hentriaconta-2,4,6(31),8,13(18),14,16,22-octaen-3-yl]acetate
수율 27%

시약·촉매·용매 5

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)촉매HCID 11763533(1,3-Bis(2,4,6-trimethylphenyl)imidazolidin-2-ylidene)(dichloro)((2-((propan-2-yl)oxy)phenyl)methylidene)ruthenium촉매HCID 111,2-Dichloroethane용매HCID 6228Dimethylformamide용매HCID 8857Ethyl Acetate용매

실험 절차

To a solution of (S)-ethyl 2-(7-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(iodomethyl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-(tert-butoxy)acetate (0.10 g, 0.171 mmol) and (S)-(4,5-difluoro-2-(pent-4-en-2-yloxy)phenyl)methanol (0.047 g, 0.205 mmol) in DMF (2 mL) was added sodium hydride (10.26 mg, 0.257 mmol) and the mixture was stirred at rt. After stirring for 4 h, the mixture was diluted with EtOAc and washed with 1N HCl followed by water and brine. The organic phase was dried (Na2SO4), filtered and concentrated. The amber oil was purified by flash chromatography (Biotage; 10% MeOH/DCM; 10 CV). The resulting impure amber oil (11.4 mg, 0.017 mmol) was taken up in DCE (4 mL). Hoveyda-Grubbs catalyst 2nd generation (2.72 mg, 4.34 μmol) then copper(I) iodide (3.31 mg, 0.017 mmol) were added and the mixture was stirred at 90° C. After 3 h, the mixture was cooled to rt and filtered and concentrated. The residue was purified by prep HPLC to give ethyl (2S)-2-(tert-butoxy)-2-[(20S,22Z)-15,16-difluoro-4,20,26-trimethyl-11,19,25-trioxa-1,5,7,8-tetraazapentacyclo[24.2.2.16,9.02,7.013,18]hentriaconta-2,4,6(31),8,13(18),14,16,22-octaen-3-yl]acetate (3.0 mg, 4.57 μmol, 27% yield). LCMS (M+H) calcd for C35H47F2N4O6: 657.34. found: 657.5.

후처리

  1. stirringAfter stirring for 4 h
  2. washwashed with 1N HCl
  3. dry with materialThe organic phase was dried (Na2SO4)
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customThe amber oil was purified by flash chromatography (Biotage; 10% MeOH/DCM; 10 CV)
  7. stirringthe mixture was stirred at 90° C
  8. temperaturethe mixture was cooled to rt
  9. filtrationfiltered
  10. concentrationconcentrated
  11. customThe residue was purified by prep HPLC

출처 및 근거

ORD 기록
ord-c1919ffc342b4c7d9547d9f1133da39f
출처 데이터셋
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09273067B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트